SIRT7 and metastatic neoplasm: On the other hand, studies have reported that the downregulation of SIRT7 expression promotes metastatic tumors, and the knockdown of SIRT7 increases the epithelial-mesenchymal transition of breast cancer cells by upregulating the TGF-β pathway, which further leads to an increase in breast cancer cell metastasis 18.